Intermezzo Coffeehouse by Monika’s Delites
featuring specialty coffees and espresso drinks,
homemade desserts, soups, sandwiches and salads.
12 Park Place, Fredonia, NY 14063
Just two doors down from its main roastery and cafe in downtown Duluth, Minn., Duluth Coffee Company recently opened an origin-inspired cocktail bar featuring locally distilled spirits in drinks modeled after traditional tipples…
To perform a dose–response meta-analysis of prospective cohort studies investigating the association between long-term coffee intake and risk of hypertension.
An online systematic search of studies published up to November 2016 was performed. Linear and non-linear dose–response meta-analyses were conducted; potential evidence of heterogeneity, publication bias, and confounding effect of selected variables were investigated through sensitivity and meta-regression analyses.
Seven cohorts including 205,349 individuals and 44,120 cases of hypertension were included. In the non-linear analysis, there was a 9% significant decreased risk of hypertension per seven cups of coffee a day, while, in the linear dose–response association, there was a 1% decreased risk of hypertension for each additional cup of coffee per day. Among subgroups, there were significant inverse associations for females, caffeinated coffee, and studies conducted in the US with longer follow-up. Analysis of potential confounders revealed that smoking-related variables weakened the strength of association between coffee consumption and risk of hypertension.
Increased coffee consumption is associated with a modest decrease in risk of hypertension in prospective cohort studies. Smoking status is a potential effect modifier on the association between coffee consumption and risk of hypertension.
The post G Grosso et al, 2017. Long-Term Coffee Consumption Is Associated with Decreased Incidence of New-Onset Hypertension: A Dose-Response Meta-Analysis, Nutrients, Volume 17, published online. appeared first on Coffee and Health.
Five years since its inception and less than a year after opening its Pentagon City flagship location, Arlington, Va.-based roaster/retailer Commonwealth Joe has closed a seed funding round of $2.5 million…
The “butter coffee” movement took a huge step into the mainstream this month as a young Austin, Texas, company called Picnik announced a deal that puts RTD bottles of its…
From the shining sea to quieter amber waves of grain, Brad Penna and Nam Ho moved from Southern California to Iowa last year on a quest to open a coffee bar and roastery in…
After years of developing commercial roasting skills, along with an appreciation for sustainable sourcing methods that benefit coffee farming communities, Hans Hochstedler and wife Joelle Hochstedler have launched a quality-focused new micro roastery in Columbus,…
One of the earliest and biggest successes in today’s now crowded RTD cold coffee category, Austin, Texas-based Chameleon Cold Brew has just branched out with new products aimed at changing public…
After some merging, reshuffling and kink-ironing in relation to its sustainability efforts following the SCAA/SCAE merger, the unified Specialty Coffee Association is launching a new sustainability conference called Avance. Importantly,…
In 1991, coffee was classified as a group 2B carcinogen, possibly carcinogenic to humans, based on limited epidemiologic evidence of a positive association with bladder cancer. In 2016, the International Agency for Research on Cancer downgraded this classification due to lack of evidence from prospective studies particularly for never smokers.
Baseline coffee drinking was assessed with a food frequency questionnaire in the NIH-AARP prospective cohort study. Among 469,047 US adults, who were cancer free at baseline, 6,012 bladder cancer cases (5,088 men and 924 women) were identified during >6.3 million person-years of follow-up. Multivariable-adjusted Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI), with non-coffee drinkers as the reference group.
Coffee drinking was positively associated with bladder cancer in models adjusted for age and sex (HR for ≥4 cups/d relative to coffee nondrinkers = 1.91, 95% CI = 1.70, 2.14; P trend < 0.0001). However, the association was substantially attenuated after adjustment for cigarette smoking and other potential confounders (HR for ≥4 cups/d relative to coffee nondrinkers = 1.18, 95% CI = 1.05, 1.33; P trend = 0.0007). Associations were further attenuated after additional adjustment for lifetime smoking patterns among the majority of the cohort with this available data (P trend = 0.16). There was no evidence of an association among never smokers (P trend = 0.84).
Positive associations between coffee drinking and bladder cancer among ever smokers but not never smokers suggest that residual confounding from imperfect measurement of smoking or unmeasured risk factors may be an explanation for our positive findings.
The post E Loftfield et al, 2017. A Prospective Investigation of Coffee Drinking and Bladder Cancer Incidence in the United States, Epidemiology, Volume 28. appeared first on Coffee and Health.
This report evaluates the scientific literature on caffeine with respect to potential cardiovascular outcomes, specifically relative risks of total cardiovascular disease (CVD), coronary heart disease (CHD) and acute myocardial infarction (AMI), effects on arrhythmia, heart failure, sudden cardiac arrest, stroke, blood pressure, hypertension, and other biomarkers of effect, including heart rate, cerebral blood flow, cardiac output, plasma homocysteine levels, serum cholesterol levels, electrocardiogram (EKG) parameters, heart rate variability, endothelial/platelet function and plasma/urine catecholamine levels. Caffeine intake has been associated with a range of reversible and transient physiological effects broadly and cardiovascular effects specifically. This report attempts to understand where the delineations exist in caffeine intake and corresponding cardiovascular effects among various subpopulations. The available literature suggests that cardiovascular effects experienced by caffeine consumers at levels up to 600 mg/day are in most cases mild, transient, and reversible, with no lasting adverse effect. The point at which caffeine intake may cause harm to the cardiovascular system is not readily identifiable in part because data on the effects of daily intakes greater than 600 mg is limited. However, the evidence considered within this review suggests that typical moderate caffeine intake is not associated with increased risks of total cardiovascular disease; arrhythmia; heart failure; blood pressure changes among regular coffee drinkers; or hypertension in baseline populations.
The post D Turnbull et al, 2017. Caffeine and Cardiovascular Health, Regulatory Toxicology and Pharmacology, Volume 89. appeared first on Coffee and Health.